ARE vs RARE · P/E 100, rev $662.8M vs rev $350.0M
Alexandria Real Estate Equities Inc (ARE) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ARE revenue for 2026-06-30 was $662.8M. Net income was -$72.8M. Revenue was down 1.2% from 2026-03-31 to 2026-06-30. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ARE currently screens at market cap $13.19B and trailing P/E 100.4. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ARE and RARE stock pages for the full models.
Not investment advice.